Promis Neurosciences (PMN) Competitors $0.39 -0.01 (-3.01%) Closing price 07/11/2025 03:56 PM EasternExtended Trading$0.40 +0.00 (+1.18%) As of 07/11/2025 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PMN vs. ZIVO, CUE, ANL, AVTX, ATRA, CRVO, RENB, AADI, KLRS, and BLUEShould you be buying Promis Neurosciences stock or one of its competitors? The main competitors of Promis Neurosciences include ZIVO Bioscience (ZIVO), Cue Biopharma (CUE), Adlai Nortye (ANL), Avalo Therapeutics (AVTX), Atara Biotherapeutics (ATRA), CervoMed (CRVO), Renovaro (RENB), Aadi Bioscience (AADI), Kalaris Therapeutics (KLRS), and bluebird bio (BLUE). These companies are all part of the "pharmaceutical products" industry. Promis Neurosciences vs. Its Competitors ZIVO Bioscience Cue Biopharma Adlai Nortye Avalo Therapeutics Atara Biotherapeutics CervoMed Renovaro Aadi Bioscience Kalaris Therapeutics bluebird bio Promis Neurosciences (NASDAQ:PMN) and ZIVO Bioscience (NASDAQ:ZIVO) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, dividends, risk, valuation, earnings and institutional ownership. Which has more risk and volatility, PMN or ZIVO? Promis Neurosciences has a beta of -0.1, indicating that its stock price is 110% less volatile than the S&P 500. Comparatively, ZIVO Bioscience has a beta of -0.06, indicating that its stock price is 106% less volatile than the S&P 500. Is PMN or ZIVO more profitable? ZIVO Bioscience's return on equity of 0.00% beat Promis Neurosciences' return on equity.Company Net Margins Return on Equity Return on Assets Promis NeurosciencesN/A -186.19% -98.56% ZIVO Bioscience N/A N/A -2,240.92% Does the media refer more to PMN or ZIVO? In the previous week, Promis Neurosciences had 1 more articles in the media than ZIVO Bioscience. MarketBeat recorded 1 mentions for Promis Neurosciences and 0 mentions for ZIVO Bioscience. Promis Neurosciences' average media sentiment score of 1.87 beat ZIVO Bioscience's score of 0.00 indicating that Promis Neurosciences is being referred to more favorably in the media. Company Overall Sentiment Promis Neurosciences Very Positive ZIVO Bioscience Neutral Which has higher earnings and valuation, PMN or ZIVO? Promis Neurosciences has higher earnings, but lower revenue than ZIVO Bioscience. Promis Neurosciences is trading at a lower price-to-earnings ratio than ZIVO Bioscience, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPromis NeurosciencesN/AN/A$2.78M-$0.05-7.81ZIVO Bioscience$15.85K3,251.07-$7.78M-$4.93-2.74 Do insiders & institutionals hold more shares of PMN or ZIVO? 50.1% of Promis Neurosciences shares are held by institutional investors. Comparatively, 12.8% of ZIVO Bioscience shares are held by institutional investors. 6.1% of Promis Neurosciences shares are held by insiders. Comparatively, 48.9% of ZIVO Bioscience shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Do analysts prefer PMN or ZIVO? Promis Neurosciences presently has a consensus target price of $4.50, suggesting a potential upside of 1,052.66%. Given Promis Neurosciences' stronger consensus rating and higher possible upside, analysts plainly believe Promis Neurosciences is more favorable than ZIVO Bioscience.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Promis Neurosciences 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00ZIVO Bioscience 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryPromis Neurosciences beats ZIVO Bioscience on 9 of the 14 factors compared between the two stocks. Get Promis Neurosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PMN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PMN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PMN vs. The Competition Export to ExcelMetricPromis NeurosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$13.16M$2.99B$5.60B$9.11BDividend YieldN/A2.39%5.24%4.02%P/E Ratio-7.8120.5827.9620.25Price / SalesN/A292.00430.8999.65Price / CashN/A42.8637.4658.16Price / Book0.787.638.045.49Net Income$2.78M-$55.05M$3.18B$250.27M7 Day Performance-15.68%8.39%3.63%4.75%1 Month Performance-24.92%5.35%4.04%7.64%1 Year Performance-82.65%1.95%29.55%16.34% Promis Neurosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PMNPromis Neurosciences3.3516 of 5 stars$0.39-3.0%$4.50+1,052.7%-81.5%$13.16MN/A-7.815Gap UpZIVOZIVO BioscienceN/A$13.94+7.2%N/A+58.8%$53.21M$15.85K-2.8610Gap DownCUECue Biopharma4.0698 of 5 stars$0.73+4.7%$3.00+309.3%-19.2%$52.76M$9.29M-1.0960Gap DownANLAdlai Nortye2.2105 of 5 stars$1.58+11.3%$9.00+469.6%-52.4%$52.40M$5M0.00127Positive NewsGap UpAVTXAvalo Therapeutics3.0036 of 5 stars$4.85+2.1%$30.00+518.6%-60.2%$51.43M$440K0.0040News CoverageATRAAtara Biotherapeutics4.4616 of 5 stars$9.27+8.0%$17.75+91.5%-9.1%$51.15M$128.94M-2.49330CRVOCervoMed3.3363 of 5 stars$6.30+7.3%$22.57+258.3%-55.1%$51.08M$9.74M-2.894Positive NewsRENBRenovaro1.9236 of 5 stars$0.31+3.1%N/A-81.4%$51.03MN/A-0.4020News CoverageAADIAadi Bioscience0.4679 of 5 stars$1.98-0.5%$1.67-15.8%+31.3%$48.90M$25.07M-0.8740KLRSKalaris TherapeuticsN/A$2.58-1.1%N/AN/A$48.81MN/A0.00110BLUEbluebird bio1.5693 of 5 stars$4.97flat$44.60+797.4%N/A$48.67M$103.95M-0.13520 Related Companies and Tools Related Companies ZIVO Bioscience Alternatives Cue Biopharma Alternatives Adlai Nortye Alternatives Avalo Therapeutics Alternatives Atara Biotherapeutics Alternatives CervoMed Alternatives Renovaro Alternatives Aadi Bioscience Alternatives Kalaris Therapeutics Alternatives bluebird bio Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PMN) was last updated on 7/12/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Promis Neurosciences Please log in to your account or sign up in order to add this asset to your watchlist. Share Promis Neurosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PMN Stock Alerts